Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07074951Recruiting
Open-label trial (2 arms), sponsored by First Saint Petersburg State Medical University. Primary endpoints: Progression of IgA Nephropathy at 120 months, Overall Remission (Partial or Complete) at 120 months and 1 more. Started Mar 2013; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07074951.